Drug Trial Radar · NCT06247085
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
70
Planned (sponsor's estimate)
Start
Dec 28, 2023
Primary completion
Aug 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Travere Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 7, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for a better way to treat people living with classical homocystinuria (HCU), a rare inherited condition. It is caused by changes in the cystathionine beta-synthase (or "CBS") gene and prevents an enzyme from working correctly in the body. This enzyme helps break down homocysteine, which is produced when the body processes methionine from protein-containing foods. This helps keep homocysteine and methionine at healthy levels. When this enzyme is not working, homocysteine and methionine build up in the blood and then spread into different tissues of the body and stop these body tissues from working normally. People living with HCU can experience problems with their vision, bones, blood vessels, thinking, learning, and memory. Available treatments for HCU include a low-methionine diet (typically achieved by limiting protein-containing foods), a methionine-free protein supplement to help meet daily protein needs, and betaine (Cystadane®). These treatments are either not sufficient or are hard to take for many patients. Pegtibatinase was designed by researchers to act like the CBS enzyme, which is missing or not working properly in people living with HCU. Researchers are studying whether adding pegtibatinase to standard treatment can lower homocysteine levels. Researchers want to learn how safe and effective pegtibatinase is, how it moves through and affects the body, and how it may affect the daily lives of people with HCU. The study plans to enroll participants from the US, Australia, Belgium, France, Germany, Ireland, Italy, Poland, Portugal, Qatar, Saudi Arabia, Spain, Turkey, and the United Kingdom. Many study visits may happen at home, depending on where you live and local regulations. Some visits may include a home nurse and telemedicine appointments with the study doctor.
Conditions
- Homocystinuria
Interventions
PegtibatinaseDrug
Pegtibatinase BIW
PlaceboOther
volume-matched saline SC BIW
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in plasma tHcy levels - Weeks 6 to 12Time frame: Weeks 6 - 12
Locations
52 sites in 14 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Recruiting
Emory University
Atlanta, Georgia · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
Maine Health - Maine Medical Center
Portland, Maine · Recruiting
Uncommon Cures
Chevy Chase, Maryland · Recruiting
The Mount Sinai Hospital
New York, New York · Recruiting
Science 37 - Virtual Site
Morrisville, North Carolina · Recruiting
Oregon Health and Science University
Portland, Oregon · Not yet recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Utah Health - The University of Utah Primary Children's Hospital
Salt Lake City, Utah · Recruiting
Royal Adelaide Hospital
Adelaide, Australia · Recruiting
Royal Children's Hospital Melbourne
Parkville, Australia · Recruiting
Westmead Hospital
Westmead, Australia · Recruiting
Cliniques Universitaires Saint-Luc
Brussels, Belgium · Recruiting
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, Belgium · Recruiting
Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Necker-Enfants Malades
Paris, France · Recruiting
CHRU Hôpitaux de Tours - Hôpital Bretonneau
Tours, France · Recruiting
Centre Hospitalier Régional Universitaire de Nancy (CHRU) - Hopitaux de Brabois - Hôpital d'enfants
Vandœuvre-lès-Nancy, France · Recruiting
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany · Not yet recruiting
Universitätsklinikum Leipzig
Leipzig, Germany · Not yet recruiting
Universitätsklinikum Münster
Münster, Germany · Not yet recruiting
Children's Health Ireland (CHI) at Temple Street
Dublin, Ireland · Recruiting
Ospedale Pediatrico Giovanni XXIII
Bari, Italy · Not yet recruiting
IRCCS Istituto Giannina Gaslini
Genova, Italy · Not yet recruiting
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Policlinico di Milano)
Milan, Italy · Not yet recruiting
Fondazione IRCCS San Gerardo Dei Tintori - Ospedale San Gerardo
Monza, Italy · Not yet recruiting
Azienda Ospedaliera di Padova
Padova, Italy · Not yet recruiting
SP ZOZ Szpital Uniwersytecki w Krakowie
Krakow, Poland · Not yet recruiting
Instytut Matki i Dziecka
Warsaw, Poland · Not yet recruiting
Instytut Pomnik-Centrum Zdrowia Dziecka
Warsaw, Poland · Recruiting
Unidade Local de Saúde de Coimbra, EPE - Hospitais da Universidade de Coimbra
Coimbra, Portugal · Recruiting
Unidade Local de Saúde de Santa Maria, EPE - Hospital de Santa Maria
Lisbon, Portugal · Recruiting
Unidade Local de Saúde de São João, EPE - Hospital São João
Porto, Portugal · Not yet recruiting
Hamad General Hospital
Doha, Qatar · Recruiting
Sidra Hospital
Doha, Qatar · Recruiting
King Abdullah International Medical Research Center
Riyadh, Saudi Arabia · Recruiting
King Faisal Specialist Hospital and Research Centre (KFSHRC) - Riyadh
Riyadh, Saudi Arabia · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.